|
TOP NEWS
ENFORCEMENT & COMPLIANCE
LITIGATION
Assertio Beats Investor Suit Over Drug, Merger Claims
By Celeste Bott
An Illinois federal judge Friday dismissed a proposed investor class action claiming Assertio misled shareholders about threats to sales of its arthritis drug Indocin, saying the company's public filings explicitly and repeatedly warned that the drug lacked patent protection and faced imminent generic competition at any time.
Opinion attached |
Read full article »
| Save to favorites »
BANKRUPTCY
LEGAL INDUSTRY
|